Life Science Denmark - Partnerships in Biotech, Pharma Clusters

Partnering Opportunities with Denmark’s Life Science Clusters – an introduction Partnering Opportunities with Denmark’s Life Science Clusters – An Introduction

Reasons for establishment in Denmark ,[object Object],[object Object],[object Object]

Denmark excels in Life Sciences activities ,[object Object],[object Object],[object Object]

Drug Development Pipeline Denmark has the 3rd largest commercial drug development pipeline in Europe (in actual numbers) (Ernst & Young 2009) Preclinical: 77 Research Phase I: 76 Phase II: 50 Phase III: 31 (Total Commercial drug development pipeline in Denmark Source: Invest in Denmark, Copenhagen Capacity 2009) Market

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Danish life sciences at a glance

Danish strongholds – Biotech cluster ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],World-class Competencies in Metabolics Source: Commercial Attractiveness of Biomedical R&D in Medicon Valley – The Role of R&D in Attracting Regional Investments , The Boston Consulting Group, 2002. Novo Nordisk annual report 2004.

Metabolic Drug Development pipeline Preclinical: 3 Research: 7 Phase I: 5 Phase II: 7 Phase III: 2 (Commercial drug development pipeline in Denmark Source: Invest in Denmark, 2006) Company highlights: Novo Nordisk, Neurosearch, 7TM, Gastrotech, Rheoscience, Stevia Pharmaceuticals, Zealand Pharma etc.

World-class Competences in Cancer Research ,[object Object],[object Object],[object Object],[object Object],Source: Commercial Attractiveness of Biomedical R&D in Medicon Valley – The Role of R&D in Attracting Regional Investments , The Boston Consulting Group, 2002.

Cancer Drug Development pipeline Preclinical: 16 Research: 21 Phase I: 8 Phase II: 8 Phase III: 7 (Commercial drug development pipeline in Denmark Source: Invest in Denmark, 2006) Company examples: Novo Nordisk, Leo Pharma, Genmab, Santaris Pharma, Symphogen, TopoTarget, Neurosearch, Pharmexa, Cellcure, NatImmune etc.

[object Object],[object Object],[object Object],[object Object],World-class competencies in Inflammatory Source: Commercial Attractiveness of Biomedical R&D in Medicon Valley – The Role of R&D in Attracting Regional Investments , The Boston Consulting Group, 2002.

Inflammatory and Infectious diseases Drug Development pipeline Preclinical: 25 Research: 6 Phase I: 6 Phase II: 15 Phase III: 7 (Commercial drug development pipeline in Denmark Source: Invest in Denmark, 2006) Company examples: Leo Pharma, TopoTarget, Action Pharma, Symphogen, 7TM, Pharmexa, Novozymes, Genmab, Arpida, Ace Biosciences etc.

Pharmaceutical Companies with Production in Denmark ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Excellent Clinical Framework

DENMARK / MEDICON VALLEY – ONE OF EUROPE´S STRONGEST CLUSTERS

Additional Life Science centres in Denmark Pharmaceutical production Medical Technology production R&D centres

Europe’s best general business framework ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: IMD World Competitiveness Yearbook 2006

DENMARK IS AN ECONOMIC HIGH-FLYER 08-09-09 Global Competitiveness Index (WEF) World Competitiveness Scoreboard (IMD) Innovation Capability Index (UNCTAD) Best Place to do Business (EIU) 2007-2008 2007 2005 2008-2012 1 USA USA Sweden Denmark 2 Switzerland Singapore Finland Finland 3 Denmark Hong Kong USA Singapore 4 Sweden Luxembourg Denmark Canada 5 Germany Denmark Norway Switzerland 6 Finland Switzerland Australia Australia 7 Singapore Iceland Canada Hong Kong 8 Japan Netherlands UK Netherlands 9 United Kingdom Sweden Belgium Sweden 10 Netherlands Canada Netherlands USA

Easy access ,[object Object],[object Object],[object Object],[object Object]

Benchmark of European locations

Our track record ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

INVEST IN DENMARK - ORGANIZATION Management Development, Marketing & Communication North America Asia Europe Life Sciences ICT Hub Danmark Renewable Energy Support Quality Assurance Creative Denmark Maritime

MISSION OF INVEST IN DENMARK ,[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

How we assist Companies contd….. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Danish Value Proposition Framework conditions Competences Establishment in Denmark Better drugs faster Collaborate

Regional Directors (4) New York Paris Tokyo Shanghai Investment Managers (23 in 12 locations) New York Paris Tokyo Shanghai Sillicon Valley London Taipei Toronto Munich Seoul India Hong Kong Partner missions (15) Dublin Madrid Auckland Brussels Vienna Beijing The Hague Zürich New Delhi Tel Aviv Bern Singapore Rome Milan

Business Solutions ,[object Object],[object Object],[object Object],[object Object],[object Object]

Thank you for your attention !

Life Science Denmark - Partnerships in Biotech, Pharma Clusters

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (12)

Similaire à Life Science Denmark - Partnerships in Biotech, Pharma Clusters

Similaire à Life Science Denmark - Partnerships in Biotech, Pharma Clusters (20)

Dernier

Dernier (20)

Life Science Denmark - Partnerships in Biotech, Pharma Clusters